BIOMAT Database Logo BIOMAT Database Logo

Discovery, synthesis, and bioactivity of bis(heteroaryl)piperazines. 1. A novel class of non-nucleoside HIV-1 reverse transcriptase inhibitors. 1994

D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Upjohn Laboratories, Kalamazoo, Michigan 49001.

A variety of analogues of 1-[4-methoxy-3,5-dimethylbenzyl]-4-[3-(ethylamino)-2-pyridyl]piperazine hydrochloride (U-80493E) were synthesized and evaluated for their inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT). Replacement of the substituted aryl moiety with various substituted indoles provided bis(heteroaryl)piperazines (BHAPs) that were 10-100-fold more potent than U-80493E. The pyridyl portion of the lead molecule was found to be very sensitive to modifications. Extensive preclinical evaluations of several of these compounds led to the selection of 1-[(5-methoxyindol-2-yl)carbonyl]-4-[3-(ethylamino)-2- pyridyl]piperazine methanesulfonate (U-87201E, atevirdine mesylate) for clinical evaluation.

UI MeSH Term Description Entries
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000631 Aminopyridines Pyridines substituted in any position with an amino group. May be hydrogenated but must retain at least one double bond. Aminopyridine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Progress of bis(heteroaryl)piperazines (BHAPs) as non-nucleoside reverse transcriptase inhibitors (NNRTIs) against human immunodeficiency virus type 1 (HIV-1).
January 2010, Mini reviews in medicinal chemistry,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.
August 2012, ACS medicinal chemistry letters,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Discovery of diarylpyridine derivatives as novel non-nucleoside HIV-1 reverse transcriptase inhibitors.
September 2009, Bioorganic & medicinal chemistry letters,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors: A Combinatorial Approach.
December 2017, Biochemistry. Biokhimiia,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
February 2004, Journal of medicinal chemistry,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Discovery and optimization of pyridazinone non-nucleoside inhibitors of HIV-1 reverse transcriptase.
August 2008, Bioorganic & medicinal chemistry letters,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Discovery of triazolinone non-nucleoside inhibitors of HIV reverse transcriptase.
August 2008, Bioorganic & medicinal chemistry letters,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
December 2011, Journal of medicinal chemistry,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
October 2008, Bioorganic & medicinal chemistry letters,
D L Romero, and R A Morge, and C Biles, and N Berrios-Pena, and P D May, and J R Palmer, and P D Johnson, and H W Smith, and M Busso, and C K Tan
Synthesis and biological evaluations of sulfanyltriazoles as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
August 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!